# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Raymond James analyst John Davis maintains Open Lending (NASDAQ:LPRO) with a Outperform and maintains $8 price target.
JMP Securities analyst David Scharf reiterates Open Lending (NASDAQ:LPRO) with a Market Outperform and maintains $8 price ta...
Canaccord Genuity analyst Joseph Vafi maintains Open Lending (NASDAQ:LPRO) with a Hold and lowers the price target from $7.5...
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.
Canaccord Genuity analyst Joseph Vafi maintains Open Lending (NASDAQ:LPRO) with a Hold and raises the price target from $5.5...